Besides, both histopathologic and positron emission tomography studies have suggested that GBA carriers were significantly more likely than noncarriers to have diffused Lewy bodies which might be associated with a higher prevalence and severity of cognitive impairment and neuropsychiatric characteristics [29, 30]. The gene discussed is GBA1; the disease is Cognitive impairment.